Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
Technology is allowing for more intelligent package solutions. Integrating tools that will satisfy regulatory requirements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback